Charlie Winkworth-Smith
Knowledge Transfer Manager, Emerging Technologies
Profile overview
Charlie is a Knowledge Transfer Manager in the Emerging Technologies group. He has a background in biomaterials, biomass valorisation and microwave process engineering. Charlie holds a PhD in Food Science from the University of Nottingham.
He leads the Neurotechnology Special Interest Group.
Talk to me
Related Events
Tue, 3 Sep
Webinar: Applicant Briefing on Mechanising and Improving Advanced Therapy ManufactureWhere:
Online Live Stream
When:
10:30
Wed, 6 Nov
Innovation Loans Open Competition Briefing Event 2019 (Belfast)Where:
Belfast, BT1 6JH
When:
09:30
5GICTRailNanoSpaceDesignEnergyHealthAviationAgri-foodAerospaceMaterialsChemistryForensicsTransportInnovationAutomotiveImmerse UKMicrobiomesHorizon 2020Urban LivingSolar EnergyEU ProgrammesManufacturingBiotechnologyCyber SecurityAI for ServicesRemanufacturingComplex SystemsNeurotechnologyIndustrial MathsSynthetic BiologyEnergy HarvestingBuilt EnvironmentInternet of ThingsMaterials SecurityGeospatial InsightsMaterials ChemistryMaritime and marineQuantum TechnologiesDefence and SecurityDigital & CreativeInfrastructure SystemsAdditive ManufacturingElectronic TechnologiesDiversity and InclusionPersonal Data and TrustSimulation and ModellingIndustrial BiotechnologyMaterials for CompositesNature Inspired SolutionsSustainable Aviation FuelAutonomous vehicles/transportAccess to Funding and FinancePosition, Navigation and TimingISCF Grand Challenge: AI and DataArtificial Intelligence in HealthISCF Grand Challenge: Clean GrowthIndustrial Strategy Challenge FundElectronics sensors & photonicsRobotics and Artificial IntelligenceISCF Grand Challenge: Ageing SocietySynthetic Biology Leadership CouncilSustainability & Circular EconomyISCF Grand Challenge: Future of mobilityUncertainty Quantification and ManagementCompound Semiconductors Special Interest GroupCommercialising Graphene and other 2D Materials...
Related Articles
03.05.2018
Opening of the Cell and Gene Therapy Catapult Manufacturing Centre in StevenageMarcel Kuiper, KTM, Health—Medicines Manufacture, shares his thoughts on the new Cell and Gene Therapy Catapult Manufacturing Centre.
25.02.2016
Synthetic biology in the real world: Case studiesThe wide-ranging applications of synthetic biology will play an important role in growing the UK's bioeconomy.
15.10.2018
Early stage companies: How do you fit in the value chain?KTN's Access to Funding and Finance team share their advice on analysing your company's value chain to show your value to investors.